Cargando…
Chondroitin sulfate-E mediates estrogen-induced osteoanabolism
Osteoporosis is an age-related disorder of bone remodeling in which bone resorption outstrips bone matrix deposition. Although anticatabolic agents are frequently used as first-line therapies for osteoporosis, alternative anabolic strategies that can enhance anabolic, osteogenic potential are active...
Autores principales: | Koike, Toshiyasu, Mikami, Tadahisa, Shida, Miharu, Habuchi, Osami, Kitagawa, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355730/ https://www.ncbi.nlm.nih.gov/pubmed/25759206 http://dx.doi.org/10.1038/srep08994 |
Ejemplares similares
-
Altered sulfation status of FAM20C-dependent chondroitin sulfate is associated with osteosclerotic bone dysplasia
por: Koike, Toshiyasu, et al.
Publicado: (2022) -
Reconsideration of the Semaphorin-3A Binding Motif Found in Chondroitin Sulfate Using Galnac4s-6st-Knockout Mice
por: Nadanaka, Satomi, et al.
Publicado: (2020) -
Osteoanabolics
por: Gupta, Vishal, et al.
Publicado: (2012) -
Osteoanabolic Agents for Osteoporosis
por: Haas, Andrea V, et al.
Publicado: (2018) -
Genetic manipulation resulting in decreased donor chondroitin sulfate synthesis mitigates hepatic GVHD via suppression of T cell activity
por: Tamura, Suguru, et al.
Publicado: (2023)